Oligonucleotide delivery platform
Therapeutics platform
A platform to deliver oligonucleotides precisely to previously untargeted cells, aimed at undruggable genes alone or combined with validated targets.
- Oligo-based modalities for tissues beyond liver, muscle and kidney
- Focus on undruggable genes
Built for
Patients with diseases in tissues beyond the liver, muscle and kidney